Open Access

Migraine and tension type headache in adolescents at grammar school in Germany – burden of disease and health care utilization

  • Lucia Albers1Email author,
  • Andreas Straube2,
  • Mirjam N Landgraf3,
  • Filipp Filippopulos2,
  • Florian Heinen3 and
  • Rüdiger von Kries1
The Journal of Headache and PainOfficial Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign against Headache"201516:52

https://doi.org/10.1186/s10194-015-0534-4

Received: 2 April 2015

Accepted: 25 May 2015

Published: 4 June 2015

Abstract

Background

Tension-type headache and migraine are among the most prevalent chronic disorders in children/adolescents. Data on health care utilization for headache in this age group, however, are sparse.

Methods

In 1399 grammar school students (aged 12–19 years) with headache in the last six months in Germany a) the burden of disease for headache (mean intensity, mean frequency in the last three months and PedMIDAS means), b) medical care utilization defined by proportion of students consulting a physician in the last 12 months and/or taking analgetic drugs in the last three months by headache types (migraine and tension-type headache) and by burden of disease were assessed.

Results

Primary headache substantially impaired daily living activities in adolescents which was mainly related to migraine. Medical care utilization and drug use, however, was low (consulting a physician: 12.0 %, 95 %-CI = [10.3-13.8]; taking analgetic drugs: 29.9 %, 95 %-CI = [27.5-32.4]) - even among students with severe headache (physician consultation: <35 %; taking analgetic drugs: <63 %). Two thirds of students with any headache and 40 % of those with migraine had neither seen a physician nor used analgetic drugs because of their headache in the preceding 12 months.

Conclusions

Adolescents with headache might too rarely seek professional help for treatment of headache. Health promotion in adolescents should increase awareness for evidence-based treatment options for headache.

Keywords

Headache Children Adolescents Health care Burden of disease

Background

Tension-type headache (TTH) and migraine are two of the most prevalent disorders in the world [1]. Migraine is the health disorder with the seventh highest impact on the quality of life and society [2]. Estimates on the prevalence and burden of disease for headache in children and adolescents vary considerably depending on age, setting, assessment etc. [3]. A recent review covering 64 headache and migraine studies in children and adolescents of the past 25 years reported an overall mean prevalence of 54.4 % for any headache and 9.1 % for migraine [4]. In the age group of 12 to 15 year old adolescents another review found a prevalence of 66 to 71% for at least one headache episode in the last three months, and 33 to 40 % for weekly headaches [5].

The burden of disease for headache in adolescents and children with respect to the impact on social functioning and quality of life is difficult to assess. A review on the impact of headache in children and adolescents stressed very inconsistent and poorly validated impact measures in most of the included studies [3]. Two important domains determining the impact of headache are suggested in this review: 1. Health status of the adolescents in terms of symptoms and illness control; 2. Functional status capturing the ability to perform activities that are essential to meet basic needs, fulfill roles and maintain well-being. In our study we assessed health status by headache frequency and pain intensity. The functional status was measured by the validated PedMIDAS questionnaire (Pediatric Migraine Disability Assessment Score) which assesses the impact of headache related to the quality of life in terms of the number of days in the last three months on which headache had a total or partial impact on schools or home life.

Optimal health care should allow coping with the challenges of headache with respect to participation in daily life and quality of life.

In adult populations medical care utilization in terms of consulting a physician and medication use is well evaluated [611]. For children and adolescents however, there are currently only very few data available which often date back at least one decade. There is only one study from Germany, which is more than nine years old [12]. From other countries there are two also older studies on health care utilization in adolescents in the United States [13,14]. There is only one recent study from Italy in younger children (aged 3 to 11 years) [15].

The aim of our study is to provide an updated assessment of a) the burden of disease for headache in grammar school students aged 12 to 19 years (both as an assessment of health status and functional status of the adolescents), b) medical care utilization of adolescents with headache in Germany defined by consulting a physician and/or taking analgetic drugs by headache types (migraine and TTH) and severity of disease.

Methods

Study population

1674 students of the 8th to 10th grade of 12 grammar schools in greater Munich (Germany) recruited for a headache intervention study (reported elsewhere [16]) filled in questionnaires about headache and risk factors for headache including questions concerning the burden of disease for headache and use of medical care and analgetic drugs. 1399 of these students, who reported at least one headache episode in the last six months, were included for this analysis.

Assessment of headache, burden of disease, medical care and use of analgetic drugs

Headache was assessed by the question “Did you experience headache?”, which could be answered with “yes, in the last seven days”, “yes in the last three months”, “yes, in the last six months”, “yes, in the last 12 months” or “no”. Students, who reported headache in the last seven days, three or six months were assumed to suffer from headache. Students, who ticked “yes” were asked further questions assessing characteristics for classifying the headache as migraine and TTH (both confirmed and probable diagnosis) according to the International Classification of Headache Disorder-III beta (ICHD-III beta) [17]. A validated pain questionnaire for children and adolescents was used and specific questions were added to further classify headache subtypes as migraine or tension-type headache (TTH) according the classification of the International Headache Society [18,19]. Individuals with both probable migraine and probable TTH criteria were given a combined diagnosis of migraine plus TTH. All subjects with headache that did not match any of these criteria for primary headache were considered to have miscellaneous headache (MiscH).

The burden of disease for headache was assessed by the following two aspects: 1) Health status of the adolescents measured by the number of headache days in the last three months and the average pain intensity; pain intensity could be ticked on a Likert scale from 1= “very mild” to 10= “very severe”. 2) The functional status: disability due to headache was assessed using PedMIDAS, a standardized questionnaire consisting of the following six questions about how much headache is affecting day-to-day activity in the last three months [20]: (Q1), How many full days of school were missed in the last three months due to headaches?”, (Q2) “How many partial days of school were missed in the last three months due to headaches (do not include full days counted in the first question)?”, (Q3) “How many days in the last three months did you function at less than half of your ability in school because of headache (do not include days counted in the first two questions)?”, (Q4) “How many days were you not able to do things at home (i.e., chores, homework, etc.) due to headache?”, (Q5) “How many days did you not participate in other activities due to headaches (i.e., play, go out, sports, etc.)?”, (Q6) “How many days did you participate in these activities, but functioned at less than half your ability (do not include days counted in the 5th question)?”. The PedMIDAS total score sums up the number of days reported in each of the questions. Disability grading scores were determined by Hershey et al. based on the PedMIDAS total score [21] with total scores of 0–10 as “little to no disability”, 11–30 as “mild disability”, 31–50 as “moderate disability”, and total scores higher than 50 as “severe disability”. PedMIDAS was shown to be a sensitive, reliable and valid assessment instrument for headache related disability in children and adolescents [20].

Usage of analgetic drugs was assessed by the question “How often in the last three months have you taken analgetic drugs to treat your headache?” which could be answered with “never”, “rarely”, “sometimes”, “nearly every time” or “every time”. Use of analgetic drugs was assumed if students reported to take at least sometimes analgetic drugs. Furthermore students were asked if they have seen a physician because of their headache in the last 12 months, which could be answered with “yes” or “no”.

Statistical analysis

For estimating the burden of disease for headache means with 95 % confidence intervals (95 %-CIs) were calculated for each of the PedMIDAS questions, the PedMIDAS total score, the pain intensity and the number of headache days in the last three months. To assess the headache type specific burden for migraine and TTH, means (with 95 %-CIs) were also given for students with a confirmed diagnosis of migraine and TTH (all other students including those with probable diagnosis of migraine or TTH were summarized as other headache types).

Group comparisons were made by comparing means or proportions and the respective binomial 95 %-CIs or formal chi-square test statistics. A sensitivity analysis was performed for different definitions of use of analgetic drugs: use of any analgetic drugs as compared to at least sometimes or regular. To assess if patients rather search sleep instead of taking drugs spearmen test and correlation coefficient between drug consumption and seeking sleep for pain relief was calculated.

Results

Table 1 shows some demographic characteristics and the proportions of headache types in the study population: there was a slight female predominance; the mean age of the students was 14.5 years; the proportions of students in each grade were rather similar; regarding the headache types similar numbers of students with migraine and TTH were observed, however, confirmed diagnosis was more common for migraine than for TTH in our study sample. The mean time period since first onset of headache was about four years. In total only 17 students reported to have headache since less than one year.
Table 1

Demographic characteristics of the study population

Age (in years) –mean (SD)

14.51 (1.09)

Gender (female) - % (N)

56.94 (796)

Grade - % (N)

8th

32.59 (456)

 

9th

38.96 (545)

 

10th

28.45 (398)

Headache types

Confirmed migraine

18.73 (262)

 

Probable migraine

10.86 (152)

 

Confirmed TTH

9.86 (138)

 

Probable TTH

19.16 (268)

 

Migraine + TTH

23.09 (323)

 

MiscH

18.30 (256)

Time period since the first headache attack (in years) – mean (SD)

4.18 (3.01)

Based on the disability grades of the PedMIDAS (Table 2) about 7 % of the students with any headache, 20 % with migraine and only 2 % with TTH were moderately to severely affected by their headache.
Table 2

Proportions of students in the PedMIDAS Disability Grades

 

PedMIDAS Disability Grades

 

Little to none

Mild

Moderate

Severe

 

(0–10)

(11–30)

(31–50)

(>50)

 

% (N)

Any headache

73.86

19.24

4.99

1.91

N = 1399

(1006)

(262)

(68)

(26)

Headache Types:

    

Migraine

48.45

31.78

13.18

6.59

N = 262

(125)

(82)

(34)

(17)

TTH

83.33

14.49

2.17

0

N = 138

(115)

(20)

(3)

(0)

Other headache types N = 999

79.30

16.56

3.21

0.93

(766)

(160)

(31)

(9)

The impact of headache on social activities assessed by the PedMIDAS questions is shown in Table 3: The number of total/partial absent days from school and of school days on which students were considerably restricted in paying attention in class because of their headache was on average 4.4 days in three months for students with any headache. Pain intensity was on average 5.5 points indicating a moderate pain intensity on average. The pain intensity differed between migraine and TTH patients (6.5/10 versus 4.9/10).
Table 3

Burden of disease in adolescents with headache

 

PedMIDAS (given as number of days in the last three month)

Pain intensity (1 = “very mild” to 10 = “very severe”)

Number of headache days in the last three months

 

Q1: absent days from school

Q2: partial absent days from school

Q3: school days with functioning < 50 % of their abilities

Q4: days where home activities could not be done

Q5: absent days from leisure activities

Q6: days with functioning < 50 % of their abilities in leisure activities

Total score (Q1 + Q2 + Q3 + Q4 + Q5 + Q6)

 

Mean [95 %-CI]

Any headache N = 1399

0.57

0.90

3.17

1.81

1.64

1.76

9.33

5.33

8.56

[0.50-0.65]

[0.77-1.03]

[2.85-3.49]

[1.61-2.01]

[1.49-1.79]

[1.56-1.96]

[8.61-10.05]

[5.30-5.37]

[8.35-8.78]

Headache Types:

         

Migraine N = 262

1.08

1.82

6.67

4.33

3.46

3.50

19.19

6.51

13.06

[0.88-1.29]

[1.35-2.29]

[5.46-7.89]

[3.49-5.16]

[2.93-4.00]

[2.70-4.30]

[16.45-21.93]

[6.44-6.57]

[12.38-13.73]

TTH N = 138

0.44

0.66

2.05

1.09

0.98

1.00

5.92

4.94

8.83

[0.25-0.63]

[0.42-0.91]

[1.61-2.49]

[0.78-1.41]

[0.64-1.32]

[0.75-1.26]

[4.78-6.97]

[4.85-5.03]

[8.27-9.39]

Other headache types N = 999

0.46

0.69

2.43

1.27

1.26

1.41

7.18

5.08

7.34

[0.37-0.54]

[0.56-0.82]

[2.14-2.73]

[1.11-1.43]

[1.12-1.39]

[1.23-1.59]

[6.56-7.80]

[5.04-5.12]

[7.11-7.46]

The average frequency of headache episodes was about nine days in the last three months for all students who had at least one headache episode in the last six months. A higher number of headache days was observed in migraine. Students suffering from migraine reported on average about 10 days with severe restrictions in school attendance in the last three months (absent days or >50 % restricted abilities to attend class). Health care utilization for headache assessed as seeing a physician in the last 12 months and use of analgetic drugs was low: 12.0 % (95 %-CI = [10.3-13.8]) of the students with headache have seen a physician and 29.9 % (95 %-CI = [27.5-32.4]) reported to take analgetic drugs. In migraine patients medical care use was higher: 24.4 % (95 %-CI = [19.3-30.1]) of migraine patients have seen a physician and 50.8 % (95 %-CI = [44.5-56.0]) took analgetic drugs.

Students who reported to take analgetic drugs never or only rarely, did not report to seek sleep more frequently instead – rather the opposite was observed: increasing use of analgetic drugs was positively associated with an incremental seeking of sleep for headache relief (r = 0.09, p = 0.0005).

Among the students with headache having seen a physician 49 % reported using analgetic drugs for management of acute headache episodes compared to 27 % of students not having consulted a physician (p < 0.001). 63.8 % of the students with any headache have neither seen a physician in the last 12 months nor took drugs. Among migraine patients 66.7 % of the students having consulted a physician reported to take analgetic drugs compared to 45.6 % of the students not having seen a physician (p < 0.005). 41.0 % of the migraine patients neither have seen a physician nor took analgetic drugs.

Irrespective of how the burden of disease was classified (PedMIDAS total scale >30, pain intensity >5 or frequency of more than 6 days of headache in the last three months), use of health care appeared to be low in general. Even in the more severe categories health care use did not exceed 60 % (physician consultation: 19 to 35 %; use of analgetic drugs: 19 to 28 %) (Table 4). As shown in a sensitivity analysis (Additional file 1: Table S1) defining use of analgetic drugs as “any use of analgetic drugs” instead of counting rare use of analgetic drugs as no use shifted these proportions about 20 % higher irrespective of the burden of disease due to headache observed.
Table 4

Frequency of medical care utilization by burden of disease for headache

  

Having seen a physician because of the headache in the last 12 months (yes)

Use of analgetic drugs (sometimes or every time)

Burden of disease

%

(N)

[95 %-CI]

PedMIDAS

moderate/severe (N = 93) (total scale >30)

35.48

62.77

(33)

(59)

[25.83-46.09]

[52.18-72.52]

little to none/mild (N = 1259) (total scale ≤30)

10.25

27.61

(129)

(349)

[08.63-12.05]

[25.16-30.17]

Pain intensity (on Likert scale from 1 to 10)

>5 (N = 625)

20.00

43.06

(125)

(270)

[16.93-23.35]

[39.15-47.04]

≤5 (N = 740)

4.73

19.05

(35)

(141)

[3.32-6.52]

[16.28-22.07]

Frequency of headache episodes

More than six headache days in the last three month (N = 529)

18.71

40.23

(99)

(214)

[15.48-22.30]

[36.03-44.53]

At most 6 headache days in the last three months (N = 858)

7.81

23.48

(67)

(201)

[6.10-9.81]

[20.68-26.47]

The PedMIDAS scores for students who consulted and students who did not consult a physician in the last year is shown in Additional file 2: Figure S1 of the supplemental material: Students who consulted a physician because of their headaches were more likely to have “mild”, “moderate” or “severe” than “mild to none” PedMIDAS scores compared to students who did not consult a physician.

Discussion

The impact of headache, especially migraine in adolescents was substantial accounting for considerable inability to attend school. However, medical care utilization was low - even among student with severe headache. Two thirds of students with any headache and 40 % of those with migraine had neither seen a physician in the preceding 12 months nor used analgetic drugs in the preceding three months.

The high burden of disease in children and adolescents with headache is in line with two previous reviews [3,4]. Three studies cited in these reviews assessed the burden of migraine by PedMIDAS and reported total scores of 17.8 to 44 days where children/adolescents were totally or partially disabled at home or at school because of migraine [2022]. However, these studies were conducted in a clinical sample which could explain the higher number of days of impairment in two of these studies. Two other population based studies reported that students missed on average 7.2 school days in the last six months due to migraine, which is comparable to our study (about 3 days in the last 3 months) [23,24].

For children and adolescents data for headache health care utilization are sparse. Most studies date back to at least one decade. There is only one recent study from Italy on medication use in pre pubertal children [15]. In a 9 year old German study (12) use of analgetic drugs and physician consultation were compared in several disorders (stomach-, back-, orofacial pain) including headache (analgetic drugs use <25 %, physician consultation ≤17 %). No differentiation by type of headache is reported in this study.

A strength of our study and a new aspect is the analysis of actual data for health care utilization of adolescents with headache in Germany in relation to type and severity of headache. Furthermore, since the study was done in an area with general high availability of health care the low consultation rate seems to reflect the students’ unawareness of the benefit of medical consultation regarding their headaches rather than lack of treatment facilities. Headache type specific estimates were confined to categories previously shown to be stable such as confirmed migraine and TTH [25]. A further strength of our study is that the burden of disease for headache was assessed by two domains: The disability due to headache using an age-adapted, validated and reliable instrument (PedMIDAS), and additional the functioning level by considering pain intensity and frequency of headache of the adolescents [20]. This is important since the retrospective assessment by PedMIDAS may be fraught with bias in both directions: 1. Underestimation for non-school days due to headache on weekend days was shown [26]. 2. Due to the retrospective assessment of the PedMIDAS, recall bias might be possible; it has been shown, that the recall of the disability due to headache in the last three months overestimates the exact number of days compared to a headache diary [27]. A further limitation could be the failure to assess distress due to headache and quality of life directly by including a general quality of life measure (like i.e. KINDL) in our questionnaire [28]. However, in a former study in grammar school students in Munich strong restriction of the quality of life by headache, especially migraine has been shown [29]. Another measure for the burden of headache could have been the duration of the headache episodes, which unfortunately was only assessed by categories precluding calculation of mean values for simple assessment of the burden for any headache/headache types. Another weakness of the study pertains to the failure to ask for prophylactic therapy in our questionnaire and the specific analgetic drugs which were used to treat the acute headache attacks. However, prophylactic medications have to be prescribed by a physician and the number of patients consulting a physician was rather low. Thus missed prophylactic drug treatment is unlikely to be high in our sample.

Ascertainment of physicians’ visits in the last year only might be an underestimate. Questions about lifetime consultations because of headache as well as about the course of headache (unchanged, improved, deteriorated) during the previous year as compared to the year before may have been useful, but unfortunately was not assessed in our study. Furthermore emergence of headache might have been too recent to allow for a doctor’s visit. As only 17 students reported to have headache since less than one year, however, it seems very unlikely that students did not consult a doctor in the last year because the time since onset of headache was too short for making an appointment.

A further source of bias could be problems in understanding the difference between analgetic drugs and prescription medication in the students. However, analgetic drug in German means any drug used for pain relief irrespective of whether the drug is prescribed or OTC and therefore this seems rather unlikely.

Limited external validity is a weakness of this paper since the study was performed in grammar school students in an urban environment. However, since grammar school students usually have a higher socioeconomic family background, it is likely that access to health care in less privileged children with headache is even lower.

Conclusion

Adolescents in Germany with primary headaches, specifically migraine, have a high burden of disease. Although health care utilization is higher in migraineurs (particularly among those more severely affected) than for other types of headache, almost 40 % of the students with migraine had neither seen a physician during the previous 12 months nor reported medical treatment. Health care promotion in adolescents should include elements to increase awareness for treatment options for headache.

Abbreviations

TTH: 

Tension-type headache

CI: 

Confidence interval

ICHD: 

International classification of headache disorder

Declarations

Acknowledgements

We would like to thank all participating students and teachers and the Bavarian ministry of education for giving the opportunity to perform this study. We also thank the DMKG (German Headache Society) which supported the study by an unrestricted fund and the German Center for Vertigo and Balance Disorders which partly funded LA.

Authors’ Affiliations

(1)
Institute of Social Paediatrics and Adolescents Medicine, Division of Epidemiology, Ludwig-Maximilians-University Munich
(2)
Department of Neurology, Ludwig-Maximilians-University Munich
(3)
Department of Paediatric Neurology and Developmental Medicine, Hauner Children’s Hospital, Ludwig-Maximilians-University Munich

References

  1. Murray CJL, Vos T, Lozano R, et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197–2223. doi: 10.1016/S0140-6736(12)61689-4Google Scholar
  2. Vos T, Flaxman AD, Naghavi M, et al. (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2163–2196. doi: 10.1016/S0140-6736(12)61729-2Google Scholar
  3. Kernick D, Campbell J (2009) Measuring the impact of headache in children: a critical review of the literature. Cephalalgia Int J Headache 29:3–16. doi:https://doi.org/10.1111/j.1468-2982.2008.01693.x View ArticleGoogle Scholar
  4. Wöber-Bingöl C (2013) Epidemiology of migraine and headache in children and adolescents. Curr Pain Headache Rep 17:341. doi:https://doi.org/10.1007/s11916-013-0341-z PubMedView ArticleGoogle Scholar
  5. Straube A, Heinen F, Ebinger F, von Kries R (2013) Headache in school children: prevalence and risk factors. Dtsch Ärztebl Int 110:811–818. doi:https://doi.org/10.3238/arztebl.2013.0811 PubMed CentralPubMedGoogle Scholar
  6. Hughes MD, Wu J, Williams TC et al (2013) The experience of headaches in health care workers: opportunity for care improvement. Headache 53:962–969. doi:https://doi.org/10.1111/head.12069 PubMedView ArticleGoogle Scholar
  7. Minen MT, Seng EK, Holroyd KA (2014) Influence of family psychiatric and headache history on migraine-related health care utilization. Headache 54:485–492. doi:https://doi.org/10.1111/head.12300 PubMedView ArticleGoogle Scholar
  8. Liu R, Yu S, He M et al (2013) Health-care utilization for primary headache disorders in China: a population-based door-to-door survey. J Headache Pain 14:47. doi:https://doi.org/10.1186/1129-2377-14-47 PubMed CentralPubMedView ArticleGoogle Scholar
  9. Abdo SA, Amood Al-Kamarany M, Alzoubi KH et al (2014) Primary headache in yemen: prevalence and common medications used. Neurol Res Int 2014:808126. doi:https://doi.org/10.1155/2014/808126 PubMed CentralPubMedView ArticleGoogle Scholar
  10. Radtke A, Neuhauser H (2012) Low rate of self-awareness and medical recognition of migraine in Germany. Cephalalgia Int J Headache 32:1023–1030. doi:https://doi.org/10.1177/0333102412454945 View ArticleGoogle Scholar
  11. Mehuys E, Paemeleire K, Van Hees T et al (2012) Self-medication of regular headache: a community pharmacy-based survey. Eur J Neurol Off J Eur Fed Neurol Soc 19:1093–1099. doi:https://doi.org/10.1111/j.1468-1331.2012.03681.x Google Scholar
  12. Hirsch C, John MT, Schaller H-G (1985) Türp JC (2006) Pain-related impairment and health care utilization in children and adolescents: a comparison of orofacial pain with abdominal pain, back pain, and headache. Quintessence Int Berl Ger 37:381–390Google Scholar
  13. Strine TW, Okoro CA, McGuire LC, Balluz LS (2006) The associations among childhood headaches, emotional and behavioral difficulties, and health care use. Pediatrics 117:1728–1735. doi:https://doi.org/10.1542/peds.2005-1024 PubMedView ArticleGoogle Scholar
  14. Lewis DW, Diamond S, Scott D, Jones V (2004) Prophylactic treatment of pediatric migraine. Headache 44:230–237PubMedView ArticleGoogle Scholar
  15. Cavestro C, Montrucchio F, Benci P et al (2014) Headache prevalence and related symptoms, family history, and treatment habits in a representative population of children in Alba, Italy. Pediatr Neurol 51:348–353. doi:https://doi.org/10.1016/j.pediatrneurol.2014.05.022 PubMedView ArticleGoogle Scholar
  16. Albers L, Heinen F, Landgraf M et al (2014) Headache cessation by an educational intervention in grammar schools: a cluster randomized trial. Eur J Neurol Off J Eur Fed Neurol Soc. doi:https://doi.org/10.1111/ene.12558 Google Scholar
  17. Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia Int J Headache 33:629–808. doi:https://doi.org/10.1177/0333102413485658 View ArticleGoogle Scholar
  18. Fendrich K, Vennemann M, Pfaffenrath V et al (2007) Headache prevalence among adolescents–the German DMKG headache study. Cephalalgia Int J Headache 27:347–354. doi:https://doi.org/10.1111/j.1468-2982.2007.01289.x View ArticleGoogle Scholar
  19. Milde-Busch A, Blaschek A, Borggrafe I, et al. (2010) Associations of diet and lifestyle with headache in high-school students: results from a cross-sectional study. Headache 50:1104–14. doi: HED1706 10.1111/j.1526-4610.2010.01706.xGoogle Scholar
  20. Hershey AD, Powers SW, Vockell AL et al (2001) PedMIDAS: development of a questionnaire to assess disability of migraines in children. Neurology 57:2034–2039PubMedView ArticleGoogle Scholar
  21. Hershey AD, Powers SW, Vockell A-LB et al (2004) Development of a patient-based grading scale for PedMIDAS. Cephalalgia Int J Headache 24:844–849. doi:https://doi.org/10.1111/j.1468-2982.2004.00757.x View ArticleGoogle Scholar
  22. D’Amico D, Grazzi L, Usai S et al (2003) Use of the Migraine Disability Assessment Questionnaire in children and adolescents with headache: an Italian pilot study. Headache 43:767–773PubMedView ArticleGoogle Scholar
  23. Hartmaier SL, DeMuro-Mercon C, Linder S et al (2001) Development of a brief 24-hour adolescent migraine functioning questionnaire. Headache 41:150–156PubMedView ArticleGoogle Scholar
  24. Smith MS, Martin-Herz SP, Womack WM, Marsigan JL (2003) Comparative study of anxiety, depression, somatization, functional disability, and illness attribution in adolescents with chronic fatigue or migraine. Pediatrics 111:e376–381PubMedView ArticleGoogle Scholar
  25. Albers L, Straube A, Landgraf MN et al (2014) High diagnostic stability of confirmed migraine and confirmed tension-type headache according to the ICHD-3 beta in adolescents. J Headache Pain 15:36. doi:https://doi.org/10.1186/1129-2377-15-36 PubMed CentralPubMedView ArticleGoogle Scholar
  26. Heyer GL, Merison K, Rose SC et al (2014) PedMIDAS-based scoring underestimates migraine disability on non-school days. Headache 54:1048–1053. doi:https://doi.org/10.1111/head.12327 PubMedView ArticleGoogle Scholar
  27. Heyer GL, Perkins SQ, Rose SC et al (2014) Comparing patient and parent recall of 90-day and 30-day migraine disability using elements of the PedMIDAS and an Internet headache diary. Cephalalgia Int J Headache 34:298–306. doi:https://doi.org/10.1177/0333102413508240 View ArticleGoogle Scholar
  28. Kröner-Herwig B, Heinrich M, Vath N (2010) The assessment of disability in children and adolescents with headache: adopting PedMIDAS in an epidemiological study. Eur J Pain Lond Engl 14:951–958. doi:https://doi.org/10.1016/j.ejpain.2010.02.010 View ArticleGoogle Scholar
  29. Milde-Busch A, Heinrich S, Thomas S et al (2010) Quality of life in adolescents with headache: results from a population-based survey. Cephalalgia Int J Headache 30:713–721. doi:https://doi.org/10.1177/0333102409354389 View ArticleGoogle Scholar

Copyright

© Albers et al. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.